Tscan therapeutics announces upcoming presentation at the 23rd annual needham virtual healthcare conference

Waltham, mass., april 02, 2024 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that the company will present at the 23rd annual needham virtual healthcare conference on tuesday, april 9, 2024 at 2:15 p.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking